Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Radiotherapy Versus Postoperative Radiotherapy After Neoadjuvant Chemotherapy ("NeoRad") in High-risk Breast Cancer: a Prospektiv, Randomized, International Multicenter Phase III Trial

NCT04261244 is registered in ClinicalTrials.gov with Bielefeld University as lead sponsor.

NCT NCT04261244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04261244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Radiotherapy Versus Postoperative Radiotherapy After Neoadjuvant Chemotherapy ("NeoRad") in High-risk Breast Cancer: a Prospektiv, Randomized, International Multicenter Phase III Trial
Lead sponsor
Bielefeld University
Phase
Phase 3
Overall status
Recruiting
Start date
February 1, 2024
Completion date
March 31, 2034
Enrollment
1,826 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer